[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

North America Biomaterial Wound Dressing Market Segmented By Product Type (Alginate Dressing, Hydrocolloids, Skin Substitute, Others), By Type (Primary, Secondary), By Application (Wounds, Burns, Ulcers, Others (Surgical & Traumatic Wounds)), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, Homecare), By Country, Competition Forecast & Opportunities, 2018-2028

October 2023 | 171 pages | ID: N21A76BECC5BEN
TechSci Research

US$ 4,400.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
North America Biomaterial Wound Dressing Market has valued at USD 660.33 million in 2022 and is anticipated to project impressive growth in the forecast period with a CAGR of 7.49% through 2028. The North America Biomaterial Wound Dressing Market presents a dynamic landscape within the broader healthcare sector. Biomaterial wound dressings, designed to facilitate wound healing and tissue regeneration, have gained substantial prominence in recent years. The North America Biomaterial Wound Dressing Market is a significant segment of the global wound care market. It has been experiencing steady growth, primarily driven by factors such as an aging population, the prevalence of chronic diseases, and an increasing number of surgical procedures.

Key Market Drivers

Innovative and Advanced Wound Dressing Products

In the North America Biomaterial Wound Dressing Market, innovation is the key to success. The relentless pursuit of creating innovative and advanced wound dressing products has become a major driver for market growth. These products incorporate cutting-edge materials and technologies, offering a range of benefits that traditional dressings simply cannot match.

Innovative wound dressings are designed to expedite the wound healing process. They often feature bioactive compounds, growth factors, and specialized materials that stimulate tissue regeneration. These advanced products come equipped with antimicrobial properties, which reduce the risk of infections in wound sites. This is particularly crucial for patients with compromised immune systems. Modern wound dressings prioritize patient comfort. They are often less intrusive, easier to apply, and more comfortable to wear, improving overall patient compliance with treatment plans. Innovative dressings typically have a longer wear time, reducing the need for frequent dressing changes. This not only saves healthcare resources but also minimizes patient discomfort.

Increasing Number of Trauma and Burn Cases

Trauma and burn cases have been on the rise in North America, contributing significantly to the demand for biomaterial wound dressings. Traumatic injuries and burns require specialized wound care, and advanced dressings have proven to be highly effective in managing these conditions.

Biomaterial wound dressings are known for their ability to create a conducive environment for tissue regeneration. This is particularly crucial in cases of traumatic injuries and burns, where rapid and efficient healing is paramount. Many advanced dressings are designed to provide pain relief by creating a protective barrier over the wound. This is especially beneficial for burn patients who often experience excruciating pain. Biomaterial wound dressings can help minimize scarring, which is a significant concern for trauma and burn patients. This not only improves aesthetics but also enhances overall quality of life.

Rising Number of Surgeries

The healthcare landscape in North America has witnessed a surge in surgical procedures. Whether elective or emergency, surgeries often result in post-operative wounds that require effective management. Biomaterial wound dressings have become the go-to choice for post-surgical wound care.

Post-surgical wounds are susceptible to infections. Biomaterial wound dressings offer a barrier against pathogens, reducing the risk of surgical site infections. Advanced dressings can accelerate the healing process, enabling patients to recover more quickly and reducing the duration of hospital stays. Biomaterial wound dressings can be tailored to specific surgical needs. They can be designed to manage exudate, promote tissue regeneration, and conform to different wound shapes.

Increasing Prevalence of Chronic Diseases

The prevalence of chronic diseases such as diabetes, obesity, and vascular disorders has been steadily increasing in North America. These conditions often lead to chronic wounds, necessitating ongoing wound care and management.

Chronic wounds require extended periods of wound care. Biomaterial wound dressings are designed to provide sustained therapeutic benefits, making them ideal for managing these cases. Biomaterial dressings can help prevent complications like infections and amputations in patients with chronic wounds, improving their overall quality of life. While chronic wound care can be costly, biomaterial dressings are seen as a cost-effective solution in the long run, as they reduce the need for frequent hospital visits and prolonged treatments.

Key Market Challenges

Regulatory Hurdles and Compliance

One of the significant challenges facing the biomaterial wound dressing market in North America is the complex regulatory landscape. The stringent regulations and rigorous approval processes imposed by agencies like the FDA (Food and Drug Administration) can create substantial barriers for manufacturers.

Obtaining regulatory approval for new biomaterial wound dressings can be a lengthy and resource-intensive process. Manufacturers must conduct extensive clinical trials and provide substantial data to demonstrate safety and efficacy. Complying with regulatory requirements involves significant financial investments. Manufacturers must ensure that their products meet rigorous standards, from product design to manufacturing processes. Small and emerging companies may struggle to navigate the regulatory maze, limiting their ability to introduce innovative wound dressing products to the market. This can stifle competition and innovation.

Cost and Pricing Pressures

The cost of biomaterial wound dressings, especially advanced and innovative products, can be a significant challenge for both patients and healthcare providers. The pricing pressures associated with these dressings can slow down market growth.

Developing biomaterial wound dressings with advanced features and capabilities often requires substantial investment in research and development. These costs can drive up the final price of the product.

Hospitals and healthcare facilities often operate under tight budgets. The cost of biomaterial wound dressings can strain these budgets, making it challenging to adopt these products on a large scale. Patients may face hurdles in obtaining insurance coverage for specialized wound dressings, leading to out-of-pocket expenses that they may find prohibitive.

Limited Awareness and Education

Another challenge is the limited awareness and education about the benefits of biomaterial wound dressings among healthcare professionals, patients, and caregivers. This lack of understanding can hinder the adoption of these advanced wound care solutions.

Healthcare professionals often rely on conventional wound care methods they are familiar with. Shifting to biomaterial wound dressings may require retraining and a change in established practices. Patients and caregivers may not be aware of the advantages of biomaterial dressings. They may be hesitant to accept new treatment options if they are not well-informed about the benefits. The wound care market is fragmented, with various products and technologies available. This can lead to confusion among stakeholders about which products are best suited for specific wound types.

Key Market Trends

Rise in Demand for Sustainable and Eco-Friendly Biomaterials

There is growing awareness about the environmental impact of healthcare products. Many patients and healthcare providers are seeking wound dressings made from sustainable and biodegradable biomaterials. This trend aligns with broader sustainability goals and reduces the carbon footprint of wound care. Regulatory bodies are increasingly promoting the use of eco-friendly materials in medical devices, including wound dressings. Compliance with these regulations has become a driving force for manufacturers to develop and market sustainable options. Patients are becoming more conscious of the materials used in their healthcare products. Biomaterial wound dressings that are perceived as environmentally friendly are gaining favor among patients, potentially influencing their treatment choices. The demand for sustainable biomaterials has spurred competition among manufacturers to develop innovative, eco-friendly wound dressings. This competitive landscape is driving the adoption of sustainable biomaterials in the market.

Advancements in Antimicrobial Biomaterials

Infections are a common concern in wound care, and antimicrobial biomaterials address this issue effectively. With the rising prevalence of antibiotic-resistant bacteria, there is a growing need for advanced wound dressings that can combat infection without relying solely on antibiotics. Patients and healthcare providers are increasingly prioritizing products that reduce the risk of wound-related infections. Antimicrobial biomaterials offer a proactive approach to infection control, enhancing patient safety and treatment outcomes. Antimicrobial biomaterials are especially valuable in managing chronic wounds, where infection control is critical. As the population ages and chronic diseases become more prevalent, the demand for these advanced dressings is on the rise. Preventing and treating infections promptly can lead to cost savings for both healthcare facilities and patients. The use of antimicrobial biomaterials can potentially reduce hospitalization and the need for additional treatments.

Telemedicine and Remote Wound Monitoring

Telemedicine and remote monitoring technologies have become more sophisticated and accessible. This trend is reshaping how wound care is delivered, making it more convenient for patients and healthcare providers. Patients in remote or underserved areas can access wound care expertise without the need for frequent in-person visits. Telemedicine allows for real-time wound assessment and monitoring, enhancing the quality of care. Telemedicine enables the collection of data on wound progression and healing rates. This data can inform treatment decisions, leading to more personalized and effective wound care plans. The COVID-19 pandemic accelerated the adoption of telemedicine across healthcare sectors, including wound care. Patients and healthcare providers have become more comfortable with remote consultations, making it a lasting trend in the market.

Segmental Insights

Product Type Insight

Based on the category of Form, the alginate dressing segment emerged as the dominant player in the North America market for Biomaterial Wound Dressing in 2022. Alginate dressings are made from seaweed-derived alginate fibers. These fibers have a remarkable ability to absorb exudate (fluid discharged from wounds) while maintaining their structural integrity. When in contact with wound exudate, alginate dressings form a gel-like substance that creates a moist wound environment ideal for healing. Alginate dressings are highly flexible and conform to the contours of the wound. This feature allows them to be used on irregularly shaped wounds, such as deep ulcers or tunneling wounds, providing full coverage and contact with the wound bed. Alginate dressings support autolytic debridement, a natural process in which the body's enzymes break down dead tissue. The gel formed by these dressings keeps the wound moist, aiding in the removal of necrotic tissue and promoting the growth of healthy granulation tissue. Exudate management is a crucial aspect of wound care. Alginate dressings excel in this regard, as they can absorb significant amounts of exudate. This capability is essential for maintaining a balanced moisture level in the wound, which promotes healing. The moist wound environment created by alginate dressings accelerates the wound healing process. By promoting cell migration, angiogenesis (the formation of new blood vessels), and granulation tissue formation, these dressings contribute to faster recovery. Patients experience less pain and discomfort during dressing changes with alginate dressings, making them more likely to adhere to their treatment plans. This can lead to better wound healing outcomes. These factors are expected to drive the growth of this segment.

Form Type Insights

Based on the category of Form, the primary biomaterial wound dressing segment emerged as the dominant player in the North America market for Biomaterial Wound Dressing in 2022. Primary biomaterial wound dressings are typically made from natural sources such as collagen, which is a major component of connective tissues in the human body. Collagen-based dressings, for example, closely mimic the body's natural environment, making them highly biocompatible. Primary biomaterial dressings promote tissue regeneration and wound healing by providing a scaffold for cells to migrate and proliferate. They support the formation of granulation tissue, blood vessel growth (angiogenesis), and the natural wound healing process. These dressings maintain a moist wound environment, which is essential for wound healing. Moisture helps in autolytic debridement (the body's natural process of removing dead tissue), reduces pain during dressing changes, and supports the activity of growth factors critical for healing.

Additionally, Primary biomaterial dressings closely resemble the body's own extracellular matrix, making them biologically relevant and conducive to tissue regeneration. This biological compatibility enhances their effectiveness in wound healing. The ability of primary biomaterial dressings to support natural tissue regeneration leads to improved wound healing outcomes. This often results in reduced scarring and better aesthetic results, which are highly desirable for patients. Healthcare professionals have confidence in the effectiveness of primary biomaterial dressings based on their biocompatibility and proven track record in clinical settings. This trust influences their choice of wound dressings for patient care. The moist wound environment created by primary biomaterial dressings reduces pain and discomfort during dressing changes. This enhances patient comfort and compliance with treatment plans, contributing to better outcomes. These factors are expected to drive the growth of this segment.

Application Insight

Based on the category of Form, the chronic wounds segment emerged as the dominant player in the North America market for Biomaterial Wound Dressing in 2022. The dominance of the wounds segment in the North America Biomaterial Wound Dressing Market can be attributed to several key factors related to the critical role wound dressings play in the healing process, the diverse range of wounds they can address, and the growing prevalence of wound-related conditions. Wound dressings are essential in the wound healing process as they create an optimal environment for the body to repair damaged tissue. They protect the wound from external contaminants, manage exudate (fluid produced by the wound), and support the natural healing mechanisms of the body.

Wound dressings are versatile and can be used to treat a wide variety of wound types, including:

Chronic Wounds: These include diabetic ulcers, venous ulcers, and pressure ulcers, which are prevalent in aging populations.

Acute Wounds: Surgical wounds, traumatic injuries, and burns are common acute wounds that require effective wound dressings.

Postoperative Care: Surgical procedures often result in wounds that require proper management to prevent infection and promote healing.

The wound care market offers specialized dressings tailored to specific wound types. For example, hydrocolloid dressings are effective for managing moderately exuding wounds, while foam dressings are suitable for wounds with heavy exudate. This variety allows healthcare professionals to select the most appropriate dressing for each patient's needs.

End-User Insights

The hospitals & clinics segment is projected to experience rapid growth during the forecast period. Hospitals and clinics are primary healthcare providers, offering a wide range of medical services. These facilities cater to patients with various healthcare needs, including those with wounds of different types and severity levels. Hospitals and clinics typically employ healthcare professionals with specialized expertise in wound care. This includes wound care nurses, surgeons, and physicians who are skilled in assessing, diagnosing, and treating complex wounds. They rely on high-quality wound dressings to achieve optimal outcomes. Hospitals and clinics handle a significant number of cases involving acute wounds, post-surgical wounds, chronic wounds, and trauma-related injuries. They require advanced wound dressings that can manage diverse wound types and exudate levels effectively. Hospitals and clinics serve a substantial patient population, making them key consumers of wound dressings. Their large patient volume increases the demand for wound care products and drives market growth.

Many hospitals and clinics have dedicated wound care centers or departments. These units are equipped with specialized equipment and personnel to manage even the most challenging wounds. To support their services, they require a steady supply of advanced wound dressings. Hospitals frequently encounter patients with complex wound cases, such as diabetic foot ulcers, pressure ulcers, and post-surgical infections. Managing these wounds effectively is essential to prevent complications and improve patient outcomes. High-quality wound dressings are integral to this process. These factors collectively contribute to the growth of this segment.

Regional Insights

United States emerged as the dominant player in the North America Biomaterial Wound Dressing market in 2022, holding the largest market share in terms of value. The United States has the largest population in North America and boasts an extensive healthcare infrastructure. It is home to numerous hospitals, clinics, wound care centers, and healthcare professionals specializing in wound management. The U.S. has a robust and diverse economy, providing the financial resources needed for extensive healthcare services and investments in advanced wound care products. The United States is a hub for medical research and innovation. It hosts major pharmaceutical companies, medical device manufacturers, and research institutions that drive advancements in biomaterial wound dressings. The sheer size of the U.S. healthcare market, coupled with a high prevalence of chronic diseases, surgeries, and trauma-related injuries, results in substantial demand for wound dressings. The U.S. healthcare system includes various reimbursement mechanisms that support the use of advanced wound dressings, making them more accessible to patients and healthcare facilities.

The Canada market is poised to be the fastest-growing market, offering lucrative growth opportunities for Biomaterial Wound Dressing players during the forecast period. Factors such as increasing its investments in healthcare, including wound care. This expansion is expected to boost the adoption of biomaterial wound dressings. Similar to the United States, Canada is experiencing an aging population, leading to a higher prevalence of chronic wounds and the need for advanced wound care solutions. There is a growing awareness of the importance of wound care and the benefits of biomaterial dressings among Canadian healthcare professionals and patients. Canadian healthcare authorities are implementing initiatives to improve wound care standards and promote the use of advanced wound dressings, further stimulating market growth.

Key Market Players


ConvaTec Group PLC

DermaRite Industries LLC

B. Braun Melsungen AG

Hollister Incorporated

Integra LifeSciences Holdings Corporation

Report Scope:

In this report, the North America Biomaterial Wound Dressing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
  • Biomaterial Wound Dressing Market, By Product Type:
    • Alginate Dressing
    • Hydrocolloids
    • Skin Substitute
    • Others
  • Biomaterial Wound Dressing Market, By Type:
    • Primary
    • Secondary
  • Biomaterial Wound Dressing Market, By Application:
    • Wounds
    • Burns
    • Ulcers
    • Others (Surgical & Traumatic Wounds)
  • Biomaterial Wound Dressing Market, End-User:
    • Hospitals & Clinics
    • Ambulatory Surgical Centers
    • Homecare
  • Biomaterial Wound Dressing Market, By Country:
    • United States
    • Canada
    • Mexico
Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the North America Biomaterial Wound Dressing Market.

Available Customizations:

North America Biomaterial Wound Dressing market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information
  • Detailed analysis and profiling of additional market players (up to five).

1.1. Market Definition
1.2. Scope of the Market
  1.2.1. Markets Covered
  1.2.2. Years Considered for Study
  1.2.3. Key Market Segmentations


2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations


3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends



5.1. Market Size & Forecast
  5.1.1. By Value
5.2. Market Share & Forecast
  5.2.1. By Product Type (Alginate Dressing, Hydrocolloids, Skin Substitute, Others)
  5.2.2. By Type (Primary, Secondary)
  5.2.3. By Application (Wounds, Burns, Ulcers, Others (Surgical & Traumatic Wounds))
  5.2.4. By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, Homecare)
  5.2.5. By Region
  5.2.6. By Company (2022)
5.3. Market Map


6.1. Market Size & Forecast
  6.1.1. By Value
6.2. Market Share & Forecast
  6.2.1. By Product Type
  6.2.2. By Type
  6.2.3. By Application
  6.2.4. By End-User
  6.2.5. By Country


7.1. Market Size & Forecast
  7.1.1. By Value
7.2. Market Share & Forecast
  7.2.1. By Product Type
  7.2.2. By Type
  7.2.3. By Application
  7.2.4. By End-User


8.1. Market Size & Forecast
  8.1.1. By Value
8.2. Market Share & Forecast
  8.2.1. By Product Type
  8.2.2. By Type
  8.2.3. By Application
  8.2.4. By End-User


9.1. Drivers & Challenges


10.1. Recent Developments
10.2. Product Launches
10.3. Mergers & Acquisitions



12.1. Business Overview
12.2. Application Offerings
12.3. Recent Developments
12.4. Key Personnel
12.5. SWOT Analysis
  12.5.1. Collagen Matrix
  12.5.2. 3M
  12.5.3. ConvaTec Group PLC
  12.5.4. DermaRite Industries LLC
  12.5.5. B. Braun Melsungen AG
  12.5.6. Hollister Incorporated
  12.5.7. Integra LifeSciences Holdings Corporation



More Publications